SECOND AMENDMENT TO THE PURCHASE AND SALE AGREEMENTThe Purchase and Sale Agreement • October 29th, 2020 • Syneos Health, Inc. • Services-commercial physical & biological research • New York
THIS SECOND AMENDMENT TO THE PURCHASE AND SALE AGREEMENT (this “Amendment”), dated as of July 25, 2019, is entered into among INVENTIV COMMERCIAL SERVICES, LLC (the “New Originator”), each of the entities listed on the signature pages hereto as an Existing Originator (each, an “Existing Originator” and collectively, the “Existing Originators” and together with the New Originator, collectively, the “Originators” and each, an “Originator”), and SYNEOS HEALTH, LLC (f/k/a INC RESEARCH, LLC), as servicer (in such capacity, the “Servicer”) and SYNEOS HEALTH RECEIVABLES LLC (the “Buyer”).
FOURTH AMENDMENT TO THE PURCHASE AND SALE AGREEMENTThe Purchase and Sale Agreement • October 29th, 2020 • Syneos Health, Inc. • Services-commercial physical & biological research • New York
THIS FOURTH AMENDMENT TO THE PURCHASE AND SALE AGREEMENT (this “Amendment”), dated as of September 25, 2020, is entered into among each of the entities listed on the signature pages hereto as a New Originator (each a “New Originator”, and collectively, the “New Originators”), each of the entities listed on the signature pages hereto as an Existing Originator (each, an “Existing Originator” and collectively, the “Existing Originators” and together with the New Originators, collectively, the “Originators” and each, an “Originator”), and SYNEOS HEALTH, LLC (f/k/a INC RESEARCH, LLC) (“Syneos Health”), as servicer (in such capacity, the “Servicer”) and SYNEOS HEALTH RECEIVABLES LLC (the “Buyer”).
NINTH AMENDMENT TO THE RECEIVABLES FINANCING AGREEMENTReceivables Financing Agreement • October 29th, 2020 • Syneos Health, Inc. • Services-commercial physical & biological research • New York
This NINTH AMENDMENT TO THE RECEIVABLES FINANCING AGREEMENT (this “Amendment”), dated as of September 25, 2020, is entered into by and among the following parties:
STOCK PURCHASE AGREEMENT BY AND BETWEEN SHCR HOLDINGS, LLC AND SYNEOS HEALTH CLINICAL, INC. DATED AS OF OCTOBER 26, 2020Stock Purchase Agreement • October 29th, 2020 • Syneos Health, Inc. • Services-commercial physical & biological research • Delaware
STOCK PURCHASE AGREEMENT, dated as of October 26, 2020 (this “Agreement”), by and between SHCR HOLDINGS, LLC, a Delaware limited liability company (“Seller”) and SYNEOS HEALTH CLINICAL INC., a Delaware corporation (“Buyer”).
